Green Strategy to Develop Novel Drug-Containing Poly (<i>ε</i>-Caprolactone)-Chitosan-Silica Xerogel Hybrid Fibers for Biomedical Applications

<div>Schematic illustration showing the facile preparation process of the PCL-CS-SiO<sub>2</sub> hybrid fibers.</div>

Journal of Nanomaterials

fig1

Figure 1

Figure 1: Green Strategy to Develop Novel Drug-Containing Poly (<i>ε</i>-Caprolactone)-Chitosan-Silica Xerogel Hybrid Fibers for Biomedical Applications 

Journal of Nanomaterials

Green Strategy to Develop Novel Drug-Containing Poly (ε-Caprolactone)-Chitosan-Silica Xerogel Hybrid Fibers for Biomedical Applications

Figure 1